Your browser doesn't support javascript.
loading
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
Kodama, Kenichiro; Kawaoka, Tomokazu; Aikata, Hiroshi; Uchikawa, Shinsuke; Nishida, Yuno; Inagaki, Yuki; Hatooka, Masahiro; Morio, Kei; Nakahara, Takashi; Murakami, Eisuke; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Masaki, Keiichi; Honda, Yoji; Mori, Nami; Takaki, Shintaro; Tsuji, Keiji; Kohno, Hirotaka; Kohno, Hiroshi; Moriya, Takashi; Nonaka, Michihiro; Hyogo, Hideyuki; Aisaka, Yasuyuki; Kimura, Tomoki; Nagata, Yasushi; Chayama, Kazuaki.
Afiliación
  • Kodama K; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Kawaoka T; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Aikata H; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Uchikawa S; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Nishida Y; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Inagaki Y; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Hatooka M; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Morio K; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Nakahara T; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Murakami E; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Tsuge M; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Hiramatsu A; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Imamura M; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Kawakami Y; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
  • Masaki K; Hiroshima City Asa Hospital, Hiroshima, Japan.
  • Honda Y; Hiroshima Red Cross Hospital, Hiroshima, Japan.
  • Mori N; Hiroshima Red Cross Hospital, Hiroshima, Japan.
  • Takaki S; Hiroshima Red Cross Hospital, Hiroshima, Japan.
  • Tsuji K; Hiroshima Red Cross Hospital, Hiroshima, Japan.
  • Kohno H; Kure Medical Center, Hiroshima, Japan.
  • Kohno H; Kure Medical Center, Hiroshima, Japan.
  • Moriya T; Chugoku Rousai Hospital, Hiroshima, Japan.
  • Nonaka M; Hiroshima General Hospital, Hiroshima, Japan.
  • Hyogo H; Hiroshima General Hospital, Hiroshima, Japan.
  • Aisaka Y; Hiroshima General Hospital, Hiroshima, Japan.
  • Kimura T; Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan.
  • Nagata Y; Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan.
  • Chayama K; Department of Medicine and Molecular Science, Division of Frontier Medical Science, Hiroshima University, Hiroshima, Japan.
Oncology ; 94(4): 215-222, 2018.
Article en En | MEDLINE | ID: mdl-29428943
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Vena Porta / Protocolos de Quimioterapia Combinada Antineoplásica / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Vena Porta / Protocolos de Quimioterapia Combinada Antineoplásica / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Año: 2018 Tipo del documento: Article País de afiliación: Japón